These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5950059)

  • 21. [Antitumor action of phenylalanine derivatives of mechlorethamine (author's transl)].
    Zhou JX; Liang HZ; Xu B
    Zhongguo Yao Li Xue Bao; 1981 Jun; 2(2):121-8. PubMed ID: 6461211
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experimental study of the anti-tumoral activity of some azotyperites with N-benzoyl asparagic acid derivative support].
    Budeanu CH; Sunel V; Iancu I; Dăneţ D; Dăneţ R
    Rev Med Chir Soc Med Nat Iasi; 1973; 77(4):817-23. PubMed ID: 4781132
    [No Abstract]   [Full Text] [Related]  

  • 23. Does coronary flow reserve assessed by blood flow velocity analysis reflect absolute coronary flow reserve?
    Takeuchi M; Nohtomi Y; Kuroiwa A
    Cathet Cardiovasc Diagn; 1996 Jul; 38(3):251-4. PubMed ID: 8804781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of colchicine and nitrogen mustard on Ehrlich's ascitic tumor in mice.
    RYAN RF; LOCHRIDGE HL; JACKSON DA
    Surg Forum; 1960; 11():47-9. PubMed ID: 13745002
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of the injection of methylbis(beta-chloroethyl) amine (caryolisine) on Ehrlich's experimental ascitic cancer].
    PELLET M; BROSSON J
    Lyon Med; 1961 Aug; 93():287-92. PubMed ID: 13734003
    [No Abstract]   [Full Text] [Related]  

  • 26. Variable drug sensitivity and chromosomal features of a cancer clone.
    Isaka H
    Gan; 1965 Oct; 56(5):443-60. PubMed ID: 4285078
    [No Abstract]   [Full Text] [Related]  

  • 27. Induced reduction of portal pressure and flow in man.
    Seldinger SI; Sundblad R
    Tijdschr Gastroenterol; 1966; 9(5):456-65. PubMed ID: 6006738
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of endoscopic injection sclerotherapy on portal blood flow and liver function.
    Sugimoto K; Shiraki K; Murata K; Ito T; Ohmori S; Sakai T; Yamanaka T; Takase K; Nakano T; Nakanishi S
    Hepatogastroenterology; 2002; 49(48):1587-90. PubMed ID: 12397742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lympho-plasmacyte response of hematopoietic marrow of rats with tumor grafts treated with immunostimulants and cytostatic drugs].
    Postică F; Barbărasă C; Mârza-Volosievici L
    Morphol Embryol (Bucur); 1980; 26(4):355-9. PubMed ID: 6450887
    [No Abstract]   [Full Text] [Related]  

  • 30. [First case of simultaneous association of high energy radiotherapy and intra-arterial injections of nitrogen mustard compounds].
    Chevalier P; Minet P; Lavigne J
    J Belge Radiol; 1965; 48(5):586-92. PubMed ID: 4954296
    [No Abstract]   [Full Text] [Related]  

  • 31. The changes of fractional flow reserve after intracoronary nitrate and Nicorandil injection in coronary artery ectasia.
    Kim W; Jeong MH; Ahn YK; Cho JG; Park JC; Kang JC
    Int J Cardiol; 2006 Nov; 113(2):250-1. PubMed ID: 16290224
    [No Abstract]   [Full Text] [Related]  

  • 32. [Regression of rat sarcoma 45 at single administration of sarcolysine, asalin and asalei].
    Syrkin AB; Solenov VN
    Farmakol Toksikol; 1969; 32(6):723-6. PubMed ID: 5381606
    [No Abstract]   [Full Text] [Related]  

  • 33. Portal blood velocity and portal blood flow in patients with chronic viral hepatitis: relation to histological liver fibrosis.
    Koda M; Murawaki Y; Kawasaki H; Ikawa S
    Hepatogastroenterology; 1996; 43(7):199-202. PubMed ID: 8682462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size.
    Bolognesi M; Sacerdoti D; Bombonato G; Merkel C; Sartori G; Merenda R; Nava V; Angeli P; Feltracco P; Gatta A
    Hepatology; 2002 Mar; 35(3):601-8. PubMed ID: 11870373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent developments in cancer chemotherapy.
    Jewers K
    Prog Drug Res; 1981; 25():275-360. PubMed ID: 7031765
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in portal blood flow volume by CO2 pneumoperitoneum in the rat].
    Schmandra TC; Gutt CN
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):565-9. PubMed ID: 14518318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of diltiazem on hepatic ischemia-reperfusion injury in rats by improving liver tissue blood flow.
    Chin S; Ikeda M; Ozaki M; Kameoka S
    Transplant Proc; 2005 Dec; 37(10):4556-9. PubMed ID: 16387169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Portal hypertension in expansive processes of the pancreas].
    Kazil P; Bumba K
    Cesk Gastroenterol Vyz; 1967 Feb; 21(2):86-94. PubMed ID: 6068609
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatic blood flow: morphologic aspects and physiologic regulation.
    Rappaport AM
    Int Rev Physiol; 1980; 21():1-63. PubMed ID: 6993392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Has my patient achieved adequate myocardial reperfusion?
    Gibson CM
    Circulation; 2003 Aug; 108(5):504-7. PubMed ID: 12900495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.